Archive | December, 2011

VisionChina Media Announces Results of 2011 Annual General Meeting of Shareholders

VisionChina Media Announces Results of 2011 Annual General Meeting of Shareholders

VisionChina Media Inc. (“VisionChina Media” or the “Company”) (Nasdaq: VISN), one of China’s largest out-of-home digital television advertising networks on mass transportation systems, today announced it has obtained shareholder approval for all matters submitted for approval at the Company’s 2011 annual general meeting, held in Hong Kong on December 28, 2011.

The following resolution proposed by the Company was approved by VisionChina Media’s shareholders:

Ratification of the appointment of Deloitte Touche Tohmatsu CPA Ltd. as the Company’s independent auditors for the year ending December 31, 2011.

Materials related to the annual general meeting of shareholders, including the proxy statement, are available on the Company’s website at http://www.visionchina.cn .

About VisionChina Media Inc.

VisionChina Media Inc. (Nasdaq: VISN) operates an out-of-home advertising network on mass transportation systems, including buses and subways. As of September 30, 2011, VisionChina Media’s advertising network included 136,777 digital television displays on mass transportation systems in 20 of China’s economically prosperous cities, including Beijing, Shanghai, Guangzhou and Shenzhen. VisionChina Media has the ability to deliver real-time, location-specific broadcasting, including news, stock quotes, weather and traffic reports, and other entertainment programming. For more information, please visit http://www.visionchina.cn .

For investor and media inquiries, please contact:

In China:

Mr. Colin Wang

Investor Relations Director

VisionChina Media Inc.

Tel: +86-135-1001-0107

Email: colin.wang@visionchina.cn

Mrs. Helen Plummer

Investor Relations Adviser

VisionChina Media Inc.

Tel: +86-139-1167-2124

Email: helen.plummer@visionchina.cn

In the United States:

Ms. Jessica Barist Cohen

Ogilvy Financial, New York

Tel: +1-646-460-9989

E-mail: jessica.cohen@ogilvy.com

SOURCE VisionChina Media Inc.

Posted in Press ReleasesComments (0)

EastBridge (EBIG) Targets Additional U.S. Clients

EastBridge (EBIG) Targets Additional U.S. Clients

EastBridge Investment Group Inc. (OTCBB: EBIG), a provider of financial services to emerging companies looking to raise capital or go public in the U.S., with clients similar to companies like Chinacast Education Corporation (NASDAQ: CAST) and A123 Systems Inc. (NASDAQ: AONE), is targeting additional U.S. clients and helping them to raise capital ahead of going public.

The company’s unique business model involves receiving a combination of cash and equity in exchange for helping these companies. Depending on the amounts of each, the firm has traditionally issued a portion of the stock received as a dividend to its own shareholders, while maintaining the balance on its books as an asset or selling it to generate revenues.

EastBridge Signs Fizza in December 2010

EastBridge entered into an agreement in December of 2010 to assist Fizza LLC in raising bridge capital of $300,000 in exchange for a combination of cash and equity. Since then, the agreement has been expanded to help the company identify legal counsel, financial advisors and capital to raise $2 million in financing to expand its business.

Fizza has developed a nutritious sparkling dairy beverage that contains all the qualitative nutrients of milk and the fun of soda. Available in orange, strawberry, apple and cola, the fat and lactose free beverages have no artificial sweeteners but all the qualitative nutrients of milk. The company is hoping to position these in both retail and educational settings.

EastBridge Signs Air Medical in October 2011

EastBridge entered into an agreement in October of 2011 to assist International Air Medical Services Inc. (IAMS) with locating legal counsel, financial advisors and capital to complete a capital raise of up to $3 million. While no financial details were disclosed yet, investors expect to see some details in the company’s upcoming SEC filings.

After receiving $176,000 in financing and completing 206 missions in its first year, the company’s predecessor (Native Air) grew to conduct about 6,000 missions per year six years later and eventually sold for $54 million. Management is now refocusing on the long range transportation segment that accounts for about 23% of emergency air medical demand.

Additional Clients in the U.S. and Abroad

As of September 2011, EastBridge was providing consulting services to eight clients to assist them with the auditing and legal processes to become public companies in the United States and become listed on a U.S. stock exchange, in addition to the aforementioned agreements. And it’s also working with Cambrium Learning (NASDAQ: ABCD) to identify a JV partner in China.

Combined, these factors make EastBridge a stock worth watching for early stage investors. For more information on the company, please see the following resources:

Posted in CommentaryComments (0)

China Direct Industries Provides Update for its Magnesium Segment Sales

China Direct Industries Provides Update for its Magnesium Segment Sales

China Direct Industries, Inc. (“China Direct Industries”) (NASDAQ:CDII), a U.S. based company that produces, sources, and distributes industrial commodities in China and the Americas and provides cross border corporate advisory services announced today that its magnesium segment operations received five new purchase contracts from existing customers, including major Fortune 500 companies, valued at approximately $11.0 million in December of 2011 for delivery over the next six months.

Commenting on the contracts, Dr. James Wang , Chairman and CEO of China Direct Industries, Inc., stated “We are pleased to see an increase in orders and quoting activity as we head into calendar 2012.  We believe that our magnesium segment will strengthen further throughout the coming year as economic conditions which weakened short term demand begin to abate.”

About China Direct Industries, Inc.

China Direct Industries, Inc. (NASDAQ: CDII), is a U.S. based company that produces, sources, and distributes industrial commodities in China and the Americas and provides business and financial consulting services.  Headquartered in Deerfield Beach, Florida with corporate offices in Shanghai, China Direct Industries’ unique infrastructure provides a platform to expand business opportunities globally while effectively and efficiently accessing the U.S. capital markets. For more information about China Direct Industries, please visit http://www.cdii.net.

DISCLOSURE NOTICE:

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, China Direct Industries, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our expectations concerning demand for our magnesium products and economic conditions.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Report on Form 10-K for the fiscal year ended September 30, 2011 .

Posted in Press ReleasesComments (0)

China Botanic Exhibits All-Natural Anti-depressant Products

China Botanic Exhibits All-Natural Anti-depressant Products

China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) (“China Botanic” or the “Company”), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines (“TCM”) in China, today announced that the Company successfully showcased its all-natural products at the 66th PHARMCHINA fair (“the Fair”) recently held in Zhengzhou, China.

China Botanic’s all-natural and plant based remedies attracted significant attention and interest from manufacturers, distributors, and other attendees at the Fair. The Company was focused on increasing knowledge and awareness of its all natural products which are beneficial in treatment and prevention of depression. Over 20 distributors expressed strong interest in the Company’s anti-depressant products and are seeking to engage in further discussion on potential partnerships. Management estimates an approximate revenue contribution of RMB5 million (or approximately $0.8 million) in fiscal year 2012 from the business generated at the fair compared to the contribution of $0.6million from last year’s fair.

“PHARMCHINA is China’s largest pharmaceutical fair which attracts attendees from all over the country, providing an ideal platform to promote our products and brand,” said Mr. Shaoming Li, Chairman and Chief Executive Officer of China Botanic. “Our focus on the anti-depressant segment reflects the growing customer demand for effective anti-depressant remedies. An estimated 30 million people in China suffer from depression, and yet China has only in recent years listed depression as a disease. We are pleased with the increased awareness we created and the response we received at the fair this year. We will continue to participate in similar events to build disease awareness and long-term brand recognition of our products. At the same time, we continue to grow our business organically and enhance our overall operational efficiency.”

ABOUT PHARMCHINA

PHARMCHINA is the largest exhibition in China’s pharmaceutical industry. With a history of over 30 years, the PHARMCHINA fair covers an area of approximately 70,000 square meters and attracts over 2,800 exhibitors and 120,000 visitors. Twice a year, exhibitors and visitors attend PHARMCHINA for new business opportunities in the rapidly developing China’s pharmaceutical market, including chemical-based drugs, TCM, bio-pharmaceuticals, OTC medicine, health care products, cosmetics, and healthcare-related technologies and other services. For more information, please visit http://en.pharmchina.com.cn/.

ABOUT CHINA BOTANIC PHARMACEUTICAL INC.

China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines (“TCM”), in the People’s Republic of China. All of the Company’s products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China. For more information, please visit www.renhuang.com.

Posted in Press ReleasesComments (0)

Search Articles

Archives